1-(2-苯并噻唑基)-5-(2-苯基-1,2,3-三唑基)-3-芳基-2-吡唑啉衍生物的合成及其荧光性能

以2-苯基-1,2,3-三唑基-4-甲醛为原料,与苯乙酮或取代苯乙酮发生羟醛缩合生成相应的查尔酮；再与2-肼基苯并噻唑反应,合成了5个含1,2,3-三唑基、苯并噻唑基的新型吡唑啉衍生物，其结构经¹H NMR、 IR和元素分析表征。荧光性能研究结果表明：该类化合物具有良好的荧光性,其最大发射波长在427～444 nm,荧光强度大小与衍生物中不同的取代基有关     

联吡唑啉类化合物的合成及其荧光性能

以1-苯基-3-甲基-5-苯氧基-吡唑-4-甲醛为原料,与苯乙酮(取代苯乙酮)发生羟醛缩合,生成相应的查尔酮,再在冰醋酸中与不同的肼反应,高产率的合成出10种新的5位含1-苯基-3-甲基-5-苯氧基-吡唑基的吡唑啉类衍生物。冰乙酸既是反应溶剂,又是催化剂,产率最高可达72%。目标化合物的结构经元素分析、红外光谱和核磁共振测试技术加以确认。化合物的荧光测定证明,化合物3a~3e发射紫色荧光,λem约为377 nm,化合物4a~4e发射蓝色荧光,λem约为480 nm。在荧光光谱中,不同取代基的联吡唑啉类化合物表现出不同的荧光强度,其中化合物4e具有最强的荧光发射,其强度值可达到4694。所合成出的化合物是一类较好的联吡唑啉类荧光化合物。     

5-甲基-1,2,4-三唑-3-硫酮类糖苷化合物的合成及抗菌活性

在KOH/丙酮体系中, 以5-甲基-4-N-取代苯基亚胺/胺基-1,2,4-三唑-3-硫酮为原料, 与溴-α-D-四乙酰葡萄糖进行Kenigs-Knorr反应合成了10个新颖的化合物—5-甲基-4-N-取代苯基亚胺基/胺基-3-S-(2',3',4',6'-四-O-乙酰基-β-D-吡喃葡萄糖基)-1,2,4-三唑(2a~2e, 5a~5e); 并在二氯甲烷/甲醇/甲醇钠混合体系中水解脱除乙酰基, 得到10个新颖的化合物—5-甲基-4-N-取代苯基亚胺基-3-S-(β-D-吡喃葡萄糖基)-1,2,4-三唑(3a~3e)及5-甲基-4-N-取代苯基胺基-3-S-(β-D-吡喃葡萄糖基)-1,2,4-三唑(6a~6e). 化合物的结构均经核磁共振波谱(NMR)、 红外光谱(IR)和高分辨质谱(HRMS)分析确证. 生物活性测试结果表明, 目标化合物对大肠杆菌、 金黄色葡萄球菌、 枯草芽孢杆菌和白色念珠球菌普遍具有较好的抗菌活性. 化合物3d和3e对4种菌株的最小抑菌浓度相对较低, 表现出较强的广谱抗菌活性.     

新型3-取代-6-(4-氯苯基)-7-(1H-1,2,4-三唑-1-基)-1',2',4'-三唑[3,4-b]-1",3",4"-噻二嗪衍生物的合成及抗菌活性

通过3-取代-4-氨基-5-巯基-1,2,4-三唑(3a～3m)和2-溴-2-(1H–1,2,4-三唑-1-基)-4′-氯代苯乙酮(2)的缩合反应,合成了13个新型3-取代-6-(4-氯苯基)-7-(1H-1,2,4-三唑-1-基)-1',2',4'-三唑[3,4-b]-1",3",4"-噻二嗪衍生物4a～4m.化合物结构经元素分析,1HNMR,IR和MS进行了表征.抗菌试验表明所合成的化合物对细菌表现出中等程度的抑制活性.     

含吡啶组块3-脂肪基-1, 2, 4-三唑并[3,4-b]-1,3,4噻二唑衍生物的合成及生物活性

分别将6种脂肪酸与二氨基硫脲反应,合成了6种含不同碳数的3-脂肪基-1,2,4-三唑(1a~1f),其中化合物1e和1f为首次合成。在三氯氧磷存在下,分别将化合物1a~1f与4-吡啶甲酸和2,6-吡啶二甲酸反应,首次高产率合成了12种三唑并噻二唑衍生物(2a~2f)和(3a~3f)。为对比引入3-脂肪基和吡啶组块对生物活性的影响,分别合成了3-苯基含吡啶组块产物(5)、双枝3-苯基含吡啶组块化合物(6)、不含吡啶组块的化合物(7a~7c)和(8a~8c)。应用IR、1H NMR和HRMS等技术手段对19种新物质进行了结构表征,并研究了其对Cdc25B和PTP1B的抑制性能,研究结果表明,含有吡啶组块的双枝脂肪基化合物3b、3d、3e和3f对Cdc25B有良好的抑制活性,IC50值(mg/L)分别为1.12±0.27、2.72±1.07、0.72±0.05和4.97±0.93;化合物2b、3d和5对PTP1B表现出较高的抑制活性,IC50值(mg/L)分别为0.98±0.13、1.33±0.11和2.18±0.20。     

1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1,2,3-三唑类衍生物的合成及抑菌活性

将邻羟苯基引入1,2,3-三唑结构中, 设计合成了10个1-(4-取代苯基)-4-苯基-5-取代-1,2,3-三唑类衍生物. 首先, 以对位取代的芳胺为原料, 经重氮化、叠氮化、闭环和缩合反应制得1-(4-取代苯基)-4-苯基-5-水杨醛亚胺-1,2,3-三唑类衍生物(3a~3e), 再用硼氢化钠还原制得1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1,2,3-三唑类衍生物(4a~4e). 目标化合物的结构经核磁、IR及元素分析确认. 抑菌活性测试表明, 当质量浓度为0.1 mg/L时, 除化合物3e和4e外, 所有化合物对白色念球菌的抑菌率均达95%以上, 对大肠杆菌的抑菌率达85%以上, 具有强抑菌活性, 表明该类化合物在抗菌药物开发方面有重要应用价值.     

新型1,2,3-三唑类化合物的合成及抗菌构效关系

根据活性基团拼接原理, 以4-取代-苯胺为原料, 经重氮化、 关环和缩合反应合成了17个化合物1-(4-取代苯基)-5-取代苯基亚氨基-4-取代-1,2,3-三唑(7a~7c和13a~13d)和1-(4-取代苯基)-5-取代苄基氨基-4-取代-1,2,3-三唑(5a~5c, 10a~10c和14a~14d), 其中化合物5a~5c, 7b, 7c, 10a, 10c, 13b~13d和14b~14c为新化合物, 对所制备化合物的结构进行了表征. 生物活性测试结果表明, 所有化合物均表现出一定的抑菌活性, 对大肠杆菌的抑菌活性均优于氟康唑; 化合物7a和10c对金黄色葡萄球菌的抑制活性明显优于氟康唑; 而化合物13a和13d则对白色念球菌表现出良好的抑制活性, 与三氯生相当.     

2,2-二甲基-5-取代苯基-3-(1,2,4-三唑-1/4-甲基)-3-戊醇类化合物的合成、表征及生物活性

取代苯甲醛经缩合、催化氢化、环氧化和开环反应合成了9种2,2-二甲基-5-取代苯基-3-(1,2,4-三唑-1-基甲基)-3-戊醇类化合物和2种2,2-二甲基-5-取代苯基-3-(1,2,4-三唑-4-基甲基)-3-戊醇类新化合物. 并对1,2,4-三唑-1-基衍生物和1,2,4-三唑-4-基衍生物的选择性合成进行了研究; 新化合物结构经质谱, ¹H NMR, 元素分析等确证, 并用单晶X射线衍射测定了化合物1a的晶体结构. 生物活性测试结果表明, 部分化合物具有强杀菌活性.     

1,5-二芳基-3-(2-羟基-4,6-二甲氧基苯基)-2-吡唑啉的合成及氟离子荧光探针行为

设计合成了8个1,5-二芳基-3-(2-羟基-4,6-二甲氧基苯基)-2-吡唑啉化合物4a~4h. 它们的结构经由IR、1H NMR、MS和元素分析确认. 测定了它们的紫外光谱和荧光光谱, 研究了它们对氟离子的选择性识别作用, 发现化合物4a,4c和4d均可选择性地识别氟离子, 其中4a和4c作为识别氟离子的荧光探针, 受常见离子干扰较小, 选择性较高.     

新型S(N)-β-D-葡萄糖苷-4-N-(取代邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑的合成及生物活性

在KOH/acetone体系中,4-N-(取代邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑-3-硫酮(3a～3d)与溴-α-D-四乙酰葡萄糖发生Kenigs-Knorr反应,合成了8个未见报道的S(N)-β-D-乙酰葡萄糖苷,其结构经1H NMR、13C NMR、红外光谱及元素分析等确定.目标化合物的生物活性测试结果表明,它们对金黄色葡萄球菌、白色念珠菌和大肠杆菌均显示了较好的抑菌活性,其效果接近或优于对照药物三氯生和氟康唑的抑菌效能.其中,化合物2-N-(2’,3’,4’,6’-O-四乙酰基-β-D-吡喃葡萄糖基)-4-N-(3,5-二溴邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑-3-硫酮(4d)及3-S-(2’,3’,4’,6’-O-四乙酰基-β-D-吡喃葡萄糖硫基)-4-N-(3,5-二溴邻羟苯基)亚胺基-5-(4-甲基-1,2,3-噻二唑)-1,2,4-三唑(5d)具有较强的抑菌活性.     

2-(取代苯乙烯基)-5-取代苯并噁唑的合成及其光性能的研究

通过2-甲基苯并噁唑或2-甲基-5-叔丁基苯并噁唑在KOH/DMF介质中与苯甲醛或取代苯甲醛反应,合成了22个标题化合物,其中13个未见报道。测定了它们的结构和紫外光谱、荧光光谱、荧光量子产率,并对母体化合物的溶剂效应进行了研究。     

Synthesis and optical behaviors of 2-(9-phenanthrenyl)-, 2-(9-anthryl)-, and 2-(1-pyrenyl)-1-alkylimidazole homologues

Eight 2-(9-phenanthrenyl)-, 2-(9-anthryl)- and 2-(1-pyrenyl)-1-alkyl-benzimidazole compounds, three 2-(9-anthryl)-1-alkylphenanthroimidazole compounds and five 4,5-diphenyl-1-alkyl-2-(9-anthryl)imidazole compounds were synthesized by alkylation reactions of the corresponding benzimidazole, phenanthroimidazole or imidazole compounds. 2-(10-Bromo-9-anthryl)-1-alkyl-benzimidazole compounds were prepared by bromination reaction of 2-(9-anthryl)-1-alkylbenzimidazole compounds. All the synthesized compounds were characterized by elemental analysis, ¹H NMR, ¹³C NMR, MS or HRMS; their absorption coefficients (), maximum absorption λ_amax, fluorescence emission maximum λ_em, Stokes shifts and fluorescence quantum yields (Φ_F) in ethyl acetate were determined; their fluorescent lifetimes (T₁ and T₂) were measured in ethyl acetate and in solid state, respectively. The crystal structure of 2-(9-anthryl)-1-n-butyl-4,5-diphenylimidazole (12a) was determined to be triclinic, space group P-1 types, using single crystal X-ray crystallography technique. The results showed that these compounds exhibited moderate fluorescence-emission abilities and higher solubility in most organic solvents than their corresponding starting materials. The relationships between the optical behaviors and structures for these compounds were discussed.     

Spectral-luminescent and solvatochromic properties of 2-(3-coumarinyl)-5-(2′-(R-amino)-phenyl)-1,3,4-oxadiazoles

Spectral-luminescent properties of the newly synthesized 2-(3^′-coumarinyl)-5-(2′-(R-amino)-phenyl)-1,3,4-oxadiazoles has been investigated in solvents of various polarity and hydrogen-bonding ability. It has been found that for all the studied compounds no excited state intramolecular proton transfer occurs despite the presence of coumarinyl fragment - electron acceptor effect of the coumarinyl fragment is not sufficient to increase the excited state acidity of the amino group. It has been found that the absorption spectra of the studied compounds shift to higher energy with increase in solvent polarity, whereas corresponding fluorescence spectra shift to lower energy with solvent polarity increase. It has been suggested that long-wavelength shifts of the fluorescence spectra of the studied compounds with increase in solvent polarity is caused by the solvent relaxation. The observed solvent relaxation effect allow us to propose some of the studied compounds as potential probes to monitor changes in solvent relaxation in low-polar media and as potential probes for rigidochromic effect.     

γ-[SiW10O36]8-夹心型稀土元素单取代多酸化合物的合成与表征

利用缺位填充法合成了12个γ-[SiW10O36]8-夹心型稀土元素单取代多酸化合物K13[Ln(SiW10O36)2]·nH2O(Ln=La3+,Ce3+,Pr3+,Nd3+,Sm3+,Eu3+,Gd3+,Tb3+,Dy3+,Ho3+,Er3+,Yb3+).通过元素分析确定其组成,由红外光谱、紫外-可见吸收光谱、循环伏安及室温磁化率测定结果确认稀土离子与γ-[SiW10O36]8-相配位;183WNMR及荧光光谱结果则表明,稀土离子处于2个γ-[SiW10O36]8-构成的八配位环境中,标题化合物具有夹心型D2d对称性结构.     

Determination of a new anti-allergenic agent, 1-[4-[3-[4-[bis-(4-fluorophenyl)hydroxymethyl]-1-piperidinyl] propoxy]-3-methoxyphenyl]ethanone, and its active acidic metabolite in plasma by high-performance liquid chromatography

High-performance liquid chromatographic (HPLC) methods were developed for the analysis of two compounds in a series of new antiallergenic agents, 1-[4-[3-[4-[bis(4-fluorophenyl)hydroxymethyl]-1-piperidinyl] propoxy]-3-methoxyphenyl]ethanone and its active acidic metabolite in plasma. The methods utilize ultraviolet or fluorescence detection, liquid-liquid extraction or solid-phase extraction and reversed-phase HPLC. The drugs were quantitated in samples from bioavailability studies performed in dogs. Calibrations were in the ng/ml concentration range for both compounds in plasma.     

4,4′-[1,n-亚烷基双[(E)-2-(4-氧苯基)乙烯基]]双吡啶的光化学性质

通过E-[4-[2-(4-羟基苯基)乙烯基]吡啶与1,n-二溴烷烃亲核取代反应合成了4,4′-[1,n-亚烷基双[(E)-2-(4-氧苯基)乙烯基]]双吡啶[n=2(Ia),3(Ib),4(Ic),6(Id)].用元素分析、红外、紫外和质子核磁共振谱鉴定了Ia～Id的结构.将Ia～Id的稀溶液用中压汞灯和低压汞灯交替照射,发现其分子内光环加成反应的存在,并且随着亚烷基碳链的延长,反应速度加快.研究还发现锌离子可以与吡啶环上氮原子发生螯合作用使分子内光环加成反应加快.本文化合物荧光很弱,在较高浓度下有较强分子间激基缔合物荧光.     

2-(5-Hydrazinocarbonyl-2-thienyl) -5, 6-methylenedioxybenzofuran and 2-(5-hydrazinocarbonyl-2-furyl)-5, 6-methylenedioxybenzofuran as novel fluorescence derivatisation reagents for carboxylic acids in liquid chromatography

The new acid hydrazides, 2-(5-hydrazinocarbonyl-2-thienyl)-5,6-methylenedioxybenzofuran (TMBH) and 2-(5-hydrazin-ocarbonyl-2-furyl)-5, 6-methylenedioxybenzofuran (FMBH), were synthesized as precolumn fluorescence derivatisation reagents for carboxylic acids in liquid chromatography. These compounds readily react with carboxylic acids in the presence of a coupling reagent under mild conditions in aqueous solution to give fluorescent derivatives. The detection limits of lauric acid were both 0.1 pmol per 10 μl injection volume at a signal-to-noise ratio of 3. The methods in which these compounds are used were applied to the assay of a standard mixture of prostaglandins (25 μM) and prostaglandins in a human seminal fluid.     

The synthesis and the solvent and substituent effect on the spectroscopic characteristic of 3-ethyl-2-(p-substitued styryl)benzothiazolium iodides

The photophysical and photochemical properties of p-substitued 2-styryl-ethylbenzothiazolium iodides, possessing different electron-withdrawing or electron-donating groups are described. The dyes were prepared by the condensation of 3-ethyl-2-methylbenzothiazole salts with p-substituted benzaldehydes. The synthesis of suitable substrates is presented as well. We describe here the absorption, emission spectra and the luminescence quantum yield of hemicyanine dyes (SH) measured in 11 different organic solvents of varying polarity. Molecular structure of the synthesized dyes was established by (1)H NMR, electronic absorption and fluorescence spectrometry. The spectral data confirmed that all the compounds exist in E-configuration of their styryl residues. The planar molecular conformation is typical for the compounds with five-membered side aromatic moieties (for example benzothiazole). The compounds possessing N-alkyl substituent in phenyl ring, in contrast to the compounds with other substituents, exhibit low fluorescence quantum yield in THF solution. This indicates that for N-alkyl derivatives the non-radiative processes are much more effective than the radiative ones. The electronic absorption and fluorescence emission spectra of tested dyes demonstrate high sensitivity to the nature of substituent introduced into the aromatic ring.     

Novel 4-Aryl-2-amino-6-(naphthalene-1-yl)-3-cyanopyridine Derivates as Potential Organic Fluorescent Materials Prepared Under Microwave Irradiation via Three-Component Domino Reactions

A green and efficient method for direct preparation of 3-cyanopyridine from aromatic aldehydes is reported. A series of novel 4-aryl-2-amino-6-(naphthalene-1-yl)-3-cyanopyridine derivates were successfully prepared by one-pot synthesis of three-component domino reactions including aromatic aldehydes, 1-acetylnaphthalene, and dicyanomethane in the presence of ammonium acetate in a solution of ethanol under microwave irradiation. This synthetic method for these compounds possesses many advantages including greater yield and shorter reaction times compared with traditional methods. The structures of these compounds were confirmed by means of high-resolution mass spectrometry, ¹H NMR, ¹³C NMR, and infrared. Moreover, the results of their fluorescent spectra showed that these compounds have good fluorescence intensity excited by the visible light wavelength of 416 nm.     

氨基苯基类中氮茚化合物的合成及作为质子探针的研究

设计合成了3个氨基苯基类中氮茚化合物, 研究了其在不同pH值的缓冲溶液中的荧光强度变化. 结果表明， 在pH=2.1～4.2之间， 该类化合物具有荧光敏感性. 化合物3a和3b可以作为良好的质子控制的荧光开关器件信号分子.